Increasing evidence emphasizes the importance of NLRP3 inflammasome activation, caspase-1 activation, and IL-1β release in the development of autoimmune diseases such as systemic lupus erythematosus, multiple sclerosis, and ulcerative colitis (39–41, 43–45). This evidence concerns the gene NLRP3 and autoimmune disease.